Corteva, Inc.

NYSE:CTVA

57.44 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 6,1124,4923,7072,5906,0454,8843,8252,7776,2524,6013,4792,3715,6274,1783,2071,8635,1913,9562,9831,9115,5566,2882,8151,9475,7316,6992,8271,8684,772.54,772.5
Cost of Revenue 3,1002,6672,3661,6463,1372,7712,5101,8793,3232,7242,2321,5583,0102,4202,1121,2972,8292,2691,9681,3493,0474,2355971,4853,6874,8471,9141,3322,5782,578
Gross Profit 3,0121,8251,3419442,9082,1131,3158982,9291,8771,2478132,6171,7581,0955662,3621,6871,0155622,5092,0532,2184622,0441,8529135362,194.52,194.5
Gross Profit Ratio 0.4930.4060.3620.3640.4810.4330.3440.3230.4680.4080.3580.3430.4650.4210.3410.3040.4550.4260.340.2940.4520.3260.7880.2370.3570.2760.3230.2870.460.46
Reseach & Development Expenses 357332357335329316340312296268316297293281305284273280290289269355422325354382383387369.5369.5
General & Administrative Expenses 1,090772700700075776465707351,67067299807245979657577476469379705556339659590000
Selling & Marketing Expenses -36-3630-300-310000-8640000000000000000000
SG&A 1,0547366446701,0457267646571,017735806672998733724597965757747646937970555633965959643668830.5830.5
Other Expenses -36-51-177-149-1341601661781791793353782983379230891125581800717100000
Operating Expenses 1,4111,0681,1761,0051,5481,2021,2701,1471,4921,1821,3011,1491,4711,1971,2101,0431,4141,2001,1981,0351,3191,4888351,0461,4261,6091,3971,2191,7611,761
Operating Income 1,601757124-315880840-104-2261,486712257-3361,146561-115-477948487-183-4731,1905651,383-584618243-190-579928928
Operating Income Ratio 0.2620.1690.033-0.1220.1460.172-0.027-0.0810.2380.1550.074-0.1420.2040.134-0.036-0.2560.1830.123-0.061-0.2480.2140.090.491-0.30.1080.036-0.067-0.310.1940.194
Total Other Income Expenses Net -263-275-556-129-194-64-99-170-159-1430735216323755-19-90-6920-152-420-460-157-4,996-246-352-280-54-563.5-563.5
Income Before Tax 1,338482-323-4441,084776-203-3961,32769824581,302791-70-507844408-187-631753491,338-5,650308-189-470-633364.5364.5
Income Before Tax Ratio 0.2190.107-0.087-0.1710.1790.159-0.053-0.1430.2120.1520.070.0030.2310.189-0.022-0.2720.1630.103-0.063-0.330.1360.0080.475-2.9020.054-0.028-0.166-0.3390.0760.076
Income Tax Expense 282106-92-129204169-162-7432512190-28284178-169-11778127-145-104270-40595-8-67272,672213242242
Net Income 1,053419-253-321714595-41-3229695641593097060041-392760272-21-494-60889-457-5,121694-2212,196-848593593
Net Income Ratio 0.1720.093-0.068-0.1240.1180.122-0.011-0.1160.1550.1230.0460.0130.1720.1440.013-0.210.1460.069-0.007-0.259-0.1090.014-0.162-2.630.121-0.0330.777-0.4540.1240.124
EPS 1.510.6-0.36-0.4510.83-0.058-0.451.340.780.220.0411.320.810.055-0.521.010.36-0.028-0.66-0.810.12-0.61-6.840.93-0.32.94-1.1330.7920.792
EPS Diluted 1.510.6-0.36-0.4510.83-0.058-0.451.330.770.220.0411.30.80.055-0.521.010.36-0.028-0.66-0.810.12-0.61-6.830.93-0.292.94-1.1330.7920.792
EBITDA 1,9131,064436-3151,5321,127200841,7881,0195983511,7571,202286-1621,337771103-1791,6261,2431,8081781,478890-113-519994.5994.5
EBITDA Ratio 0.3130.2370.118-0.1220.2530.2310.0520.030.2860.2210.1720.1480.3120.2880.089-0.0870.2580.1950.035-0.0940.2930.1980.6420.0910.2580.133-0.04-0.2780.2080.208